📚 Module Overview
Atrial fibrillation (AF) is a heart condition that causes an irregular and often abnormally fast heart rate. It is the most common heart rhythm disturbance. A key concern with AF is that it increases the risk of stroke by five times compared to people without the condition. Atrial flutter is a related condition that is managed in the same way.
The prevalence of AF is strongly related to age, affecting only 0.2% of those under 55 but rising to 10% in individuals over 85. The management of AF focuses on two main goals, which can be remembered as 'AC for AF': Avoiding stroke and having a Control strategy for heart rate or rhythm.
For practical purposes, 'valvular AF' refers to patients with moderate-to-severe mitral stenosis or a mechanical heart valve. Patients with this type of AF should be treated with warfarin. Direct-acting oral anticoagulants (DOACs) are licensed only for 'non-valvular AF'.
💊 Pharmacology Guide
This section provides a summary of pharmacological management based on UK guidelines.
Anticoagulation for Stroke Prevention
| Treatment Line | Medication Examples & Dosing | Monitoring & Alerts | Duration |
|---|---|---|---|
| First-Line | Direct-Acting Oral Anticoagulants (DOACs) - Apixaban: 5mg BD (reduce to 2.5mg BD if 2 of: age ≥80, weight ≤60kg, creatinine ≥133 µmol/L) - Rivaroxaban: 20mg OD (reduce to 15mg OD if CrCl 15-49 mL/min) - Edoxaban: 60mg OD (reduce to 30mg OD if CrCl 15-50 mL/min, weight ≤60kg, or on certain P-gp inhibitors) |
Baseline: U&Es, LFTs, FBC, Coagulation screen. Ongoing: Renal function (U&Es) at least annually, more often in elderly or if declining. Alerts: Risk of bleeding. Counsel on signs (see OSCE section). Avoid concurrent NSAIDs. |
Lifelong |
| Second-Line | Vitamin K Antagonist (VKA) - Warfarin - Dose: Variable, adjusted according to INR. Typical starting dose 5-10mg, then adjusted. Target INR usually 2.5 (range 2.0-3.0). |
Baseline: As for DOACs. Ongoing: Frequent INR checks (initially every few days, then up to every 12 weeks once stable). Alerts: Numerous drug/food interactions. Bleeding risk. Requires consistent diet. |
Rate Control Strategy
| Treatment Line | Medication Examples & Dosing | Monitoring & Alerts | Duration |
|---|---|---|---|
| First-Line | Beta-blocker (e.g., Bisoprolol) or Rate-limiting CCB (e.g., Diltiazem MR) - Bisoprolol: Start 1.25-2.5mg OD, titrate up as needed. - Diltiazem MR: Start 90-120mg BD or 180-240mg OD, titrate up. |
Monitoring: Heart rate, blood pressure, symptom review. Alerts: Avoid CCBs in heart failure. Side effects: bradycardia, fatigue (beta-blockers), ankle swelling (CCBs). |
Lifelong |
| Second-Line | Combination Therapy - Add Digoxin to a Beta-blocker or CCB. - Or combine a Beta-blocker and a CCB (specialist advice recommended). - Digoxin: Loading dose may be used; maintenance 62.5-250mcg OD. |
Monitoring: As above. For Digoxin: monitor U&Es (risk of toxicity in hypokalaemia/renal decline). Check levels if toxicity suspected. Alerts: Digoxin toxicity (nausea, confusion, vision changes). |
|
| Third-Line | Specialist Input - May involve seeking a rhythm control strategy or considering amiodarone for rate control if other options fail (uncommon). |
Requires specialist oversight. Amiodarone has significant side effects (thyroid, lung, liver) and requires extensive monitoring (TFTs, LFTs, CXR). |
🔍 Diagnosis & Assessment
NICE recommends a case-finding approach to detect AF, which involves checking for an irregular pulse in people who present with indicative symptoms. It does not recommend systematic screening for the general population.
Symptoms & Investigations
Be alert for AF in patients presenting with:
- Palpitations or chest discomfort
- Breathlessness
- Dizziness or syncope (fainting)
- Stroke or a transient ischaemic attack (TIA)
- ECG: A 12-lead ECG is required to confirm a diagnosis of AF. If paroxysmal (intermittent) AF is suspected, a 24-hour ambulatory ECG or event recorder may be needed.
- Blood Tests: Routine blood tests such as FBC, U&Es, LFTs, and TSH are standard practice before starting treatment.
- Echocardiogram: This is not needed routinely. It is indicated if there is evidence of structural heart disease, if cardioversion is planned, or to help stratify stroke risk.
🧠 A - AVOID STROKE: Risk Assessment & Anticoagulation
The first priority in managing AF is to assess the patient's risk of stroke and their risk of bleeding from anticoagulant therapy. For most individuals, the benefit of anticoagulation in preventing a stroke significantly outweighs the risks.
Assessing Stroke and Bleeding Risk
Two scoring tools are used to guide the decision-making process:
| Risk Assessment Tool | Purpose & Scoring |
|---|---|
| CHA₂DS₂-VASc Score (Stroke Risk) |
Used to estimate the annual risk of stroke in a patient with AF.
|
| ORBIT Score (Bleeding Risk) |
This tool is now recommended by NICE over HAS-BLED. It helps to identify and manage modifiable bleeding risk factors (e.g., uncontrolled hypertension, NSAID use). It is not used to rule out anticoagulation but to guide safer management. |
🫀 C - CONTROL STRATEGY: Rate or Rhythm Control?
The second goal of AF management is to control the patient's symptoms and heart rate. For most patients, rate control is the first-line approach.
A rhythm control strategy is considered for a minority of patients, including those who have new-onset AF, have AF with a clear reversible cause, have AF-induced heart failure, or are younger or remain symptomatic despite adequate rate control.
⭐ Bonus: Clinical Case Study
Clinical Challenge: Suboptimal Rate Control
Patient Profile: Mrs. Jones is a 78-year-old woman with a history of persistent AF (diagnosed 2 years ago), hypertension, and osteoarthritis. She attends for a routine medication review.
Current Medications: Apixaban 5mg BD, Ramipril 5mg OD, Bisoprolol 5mg OD, Paracetamol 1g QDS prn.
S (Subjective): Mrs. Jones reports feeling more tired than usual and occasionally feels her heart is "racing", especially when she walks to the shops. She feels a bit breathless at these times. She denies any chest pain. She is taking her medications correctly.
O (Objective): Blood pressure is well-controlled at 134/78 mmHg. Her heart rate, checked in the pharmacy, is irregular and 118 bpm at rest. Her latest renal function (2 months ago) was normal.
A (Assessment): Mrs. Jones is experiencing symptomatic AF with resting tachycardia, indicating her current dose of bisoprolol (5mg) provides inadequate rate control. Her anticoagulant and blood pressure management appear appropriate.
P (Plan):
- Medication Change: Recommend increasing the bisoprolol dose. Contact her GP to suggest titrating bisoprolol up to 7.5mg OD.
- Counselling: Explain to Mrs. Jones why the change is needed and what to expect.
- Monitoring: Advise her to monitor for signs of excessive bradycardia (dizziness, severe fatigue) after the dose increase. The GP should re-check her heart rate in 2-4 weeks.
- Safety Netting: Advise her to contact her GP sooner if her symptoms worsen or if she feels very dizzy or unwell.
Example Dialogue:
Pharmacist: "Hello Mrs. Jones. Thanks for coming in. You mentioned feeling tired and that your heart is racing sometimes. We've just checked your pulse and it is a bit fast today, even while you're resting."
Patient: "Oh, is it? I thought the heart tablet was supposed to stop that."
Pharmacist: "It is, and it's doing a good job, but it looks like we might need to adjust the dose to get your heart rate into a more comfortable range. Your current dose of bisoprolol might not be quite strong enough anymore. I'm going to suggest to your GP that we increase it slightly, from 5mg to 7.5mg. This should help to slow the heart rate down a bit more and help you feel less breathless and tired."
Patient: "Will it give me any side effects?"
Pharmacist: "Most people handle a small increase like this very well. We just need to watch out for it slowing things down too much. If you start to feel unusually dizzy or exhausted, just let your GP practice know. Otherwise, they'll likely want to re-check your pulse in a few weeks to see how you're getting on. How does that sound?"
🌳 Lifestyle and Patient Support Resources
Holistic Care and Signposting
Managing AF effectively also involves addressing lifestyle factors that can impact heart health. Here are some key UK resources for patients and clinicians.
- British Heart Foundation (BHF): Provides extensive information, recipes, and tips for a heart-healthy diet.
- NHS Eat Well Guide: The UK's national guide to healthy eating, explaining the main food groups for a balanced diet.
- British Heart Foundation (BHF): Offers guidance on staying active with a heart condition, including AF.
- NHS - Exercise: Provides physical activity guidelines for adults and tips on how to get active safely.
- NHS Smokefree: The primary NHS resource offering free support, apps, and advice to help people quit smoking.
- Drinkaware: A national charity providing information and tools to help people make better choices about their drinking.
- The AF Association: A patient-focused charity providing information, support, and resources specifically for people affected by atrial fibrillation.
🎯 OSCE Preparation
Counselling a Patient Newly Diagnosed with AF
Scenario: Mr. Smith, a 76-year-old man, has just been diagnosed with Atrial Fibrillation after visiting his GP with palpitations. His past medical history includes well-controlled hypertension. His GP has sent him to the pharmacy with a prescription for apixaban and asks you to explain the new diagnosis and medication.
Key Communication & Counselling Steps:- Introduce & Set the Scene: "Hello Mr. Smith, I'm the pharmacist. Your GP has asked me to have a chat with you about your new medication. Can we talk somewhere private? I understand you've recently been diagnosed with something called Atrial Fibrillation. How are you feeling about that?"
- Explain AF Simply: "AF is quite common, especially as we get older. It means the top chambers of your heart are beating irregularly, a bit like a drum that's lost its rhythm. For many people, the main issue isn't the rhythm itself, but that it can increase the risk of a stroke. This is because the irregular beat can allow small blood clots to form in the heart."
- Explain the Risk Scores (Patient-Friendly Language): "To work out your specific risk, we use a scoring system. Because of your age and history of high blood pressure, your score is high enough that we strongly recommend a treatment to prevent clots. We also check your risk of bleeding to make sure the treatment is as safe as possible for you."
- Introduce the Anticoagulant (The 'Blood Thinner'): "This medication, apixaban, is what we call an anticoagulant, or a 'blood thinner'. It doesn't actually thin your blood, but it works by making it less likely to form those harmful clots. This will significantly reduce your risk of having a stroke."
- Counsel on Key Safety Points: "Because this medicine makes you less likely to clot, you need to be aware of a few things. You might notice you bruise more easily or bleed for a bit longer if you cut yourself. It's really important to look out for any signs of serious bleeding, like blood in your poo or wee, coughing up blood, or very severe bruising, and to let a doctor know straight away. Always tell any other healthcare professional, like your dentist, that you are taking apixaban."
- Emphasise Adherence: "This medication works best when you take it exactly as prescribed, every day. Unlike some older medicines, its effect wears off quite quickly, so it's vital not to miss any doses to ensure you stay protected from a stroke."
- Check Understanding & Close: "I know that's a lot of information. To make sure I've explained it clearly, could you tell me in your own words why you're taking this new tablet? ... Great. The plan is to take this regularly to protect you from a stroke. Do you have any questions for me?"
✅ Test Your Knowledge
You've completed the module. Test your understanding with our comprehensive quiz.